Hormono-depending Adjuvant Breast Cancer Clinical Trial
Official title:
Breast Cancer Adjuvant Hormonotherapy : Tamoxifen and the Anti-aromatases Pharmacokinetics, Correlation With the Pharmacogenetic Characteristics PHACS Protocol : Pharmacology of Adjuvant Hormonotherapy in Breast Cancer
This is a biomedical study of interventional type, multicenter, inter-regional.
Patients with hormono-depending breast cancer, for which an indication of adjuvant
hormonotherapy treatment (according to the current treatments) was retained, will be enrolled
in this study. The main objective is to estimate the correlations between pharmacokinetic and
pharmacogenetic parameters of adjuvant hormonal breast cancer treatment, during the first 3
years.
n/a